Podcast — Altasciences’ Clinical Trial Monitoring

Altasciences’ clinical trial monitoring solutions will help progress your study from initiation to final close-out efficiently, while saving you time and costs. Our team of highly experienced, well-trained CRAs, will work with you throughout the conduct of your clinical trial to ensure strict adherence to protocol and regulations, subject safety, and accurate visit reporting.

Learn more about the benefits of working with Altasciences’ CRAs for your clinical trial monitoring needs.

Video — A Seamless CRO Experience 

At Altasciences, our integrated, full-service solutions from lead candidate selection to clinical proof of concept are all customizable to your specific needs.

Watch as Ingrid Holmes, Vice President, Global Clinical Operations, discusses how we help sponsors bring better drugs to market, faster.

Contact our experts to learn more about our integrated drug development solutions.

September 2020

In this issue
Examine our bioanalytical assay list, new scientific publications, webinars, podcasts, and more, covering our full-service preclinical, clinical and manufacturing solutions…

INDUSTRY NEWS

See what Altasciences has been up to!

READ MORE

Key Considerations for a Successful Ligand Binding Program
Preclinical to clinical bioanalytical expertise at Altasciences

READ THE ARTICLE

Challenges in Early Phase Clinical Pharmacology Studies
Importance of integration and eliminating organizational silos

READ THE ARTICLE

The Altascientist
Central nervous system (CNS) active drugs — complex considerations.

READ MORE

CONTINUE READING

  • Webinars
    Register for upcoming complimentary webinars and view the latest ones on-demand!
  • Podcasts
    Listen to podcasts covering industry hot topics!
  • Up Close and Personal with…
    Meet Joseph A. Francisco
  • Blog
    Enjoy Dr. Francisco’s commentary on the FDA guidance related to COVID-19 vaccines, and other insightful posts.

LET'S STAY CONNECTED!

Identifying Appropriate Outcome Measures and Methodology to Evaluate the Abuse, Misuse, Dependence, and Impairing Effects of CNS-Active Drugs in Healthy Volunteer and Patient Trials

Subscribe to